The biopharmaceutical CMO and CRO market is estimated to be valued at US$ 32.4 Bn in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The biopharmaceutical CMO and CRO market refers to the outsourcing of manufacturing and research services by pharmaceutical companies. These...